Revvity Gross Margin 2010-2025 | RVTY
Current and historical gross margin for Revvity (RVTY) over the last 10 years. The current gross profit margin for Revvity as of March 31, 2025 is %.
| Revvity Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $2.77B | $1.56B | 56.28% |
| 2024-12-31 | $2.76B | $1.54B | 55.83% |
| 2024-09-30 | $2.72B | $1.51B | 55.44% |
| 2024-06-30 | $2.71B | $1.50B | 55.26% |
| 2024-03-31 | $2.73B | $1.51B | 55.50% |
| 2023-12-31 | $2.75B | $1.54B | 55.94% |
| 2023-09-30 | $2.80B | $1.59B | 56.94% |
| 2023-06-30 | $2.84B | $1.63B | 57.31% |
| 2023-03-31 | $3.02B | $1.78B | 58.73% |
| 2022-12-31 | $3.31B | $1.99B | 60.08% |
| 2022-09-30 | $3.00B | $2.00B | 66.48% |
| 2022-06-30 | $3.15B | $2.11B | 67.02% |
| 2022-03-31 | $3.48B | $2.24B | 64.45% |
| 2021-12-31 | $3.83B | $2.43B | 63.60% |
| 2021-09-30 | $3.63B | $2.44B | 67.18% |
| 2021-06-30 | $3.74B | $2.44B | 65.44% |
| 2021-03-31 | $3.32B | $2.21B | 66.47% |
| 2020-12-31 | $2.66B | $1.73B | 64.93% |
| 2020-09-30 | $3.23B | $1.68B | 51.96% |
| 2020-06-30 | $2.98B | $1.50B | 50.24% |
| 2020-03-31 | $2.89B | $1.40B | 48.35% |
| 2019-12-31 | $2.88B | $1.40B | 48.40% |
| 2019-09-30 | $2.84B | $1.37B | 48.47% |
| 2019-06-30 | $2.80B | $1.36B | 48.68% |
| 2019-03-31 | $2.78B | $1.36B | 48.74% |
| 2018-12-31 | $2.78B | $1.34B | 48.25% |
| 2018-09-30 | $2.66B | $1.27B | 47.73% |
| 2018-06-30 | $2.54B | $1.21B | 47.50% |
| 2018-03-31 | $2.39B | $1.13B | 47.17% |
| 2017-12-31 | $2.26B | $1.07B | 47.59% |
| 2017-09-30 | $2.18B | $1.04B | 47.85% |
| 2017-06-30 | $2.14B | $1.02B | 47.81% |
| 2017-03-31 | $2.13B | $1.02B | 47.86% |
| 2016-12-31 | $2.12B | $1.02B | 47.99% |
| 2016-09-30 | $2.00B | $0.96B | 48.02% |
| 2016-06-30 | $2.05B | $0.97B | 47.17% |
| 2016-03-31 | $2.08B | $0.97B | 46.48% |
| 2015-12-31 | $2.11B | $0.97B | 45.84% |
| 2015-09-30 | $2.10B | $0.95B | 45.39% |
| 2015-06-30 | $2.07B | $0.94B | 45.27% |
| 2015-03-31 | $2.07B | $0.93B | 45.21% |
| 2014-12-31 | $2.07B | $0.94B | 45.17% |
| 2014-09-30 | $2.22B | $1.00B | 45.22% |
| 2014-06-30 | $2.20B | $0.99B | 45.18% |
| 2014-03-31 | $2.18B | $0.99B | 45.21% |
| 2013-12-31 | $2.16B | $0.98B | 45.25% |
| 2013-09-30 | $2.13B | $0.96B | 45.05% |
| 2013-06-30 | $2.12B | $0.96B | 45.21% |
| 2013-03-31 | $2.10B | $0.96B | 45.48% |
| 2012-12-31 | $2.11B | $0.96B | 45.68% |
| 2012-09-30 | $2.08B | $0.94B | 45.20% |
| 2012-06-30 | $2.03B | $0.91B | 44.89% |
| 2012-03-31 | $1.98B | $0.88B | 44.35% |
| 2011-12-31 | $1.92B | $0.85B | 44.16% |
| 2011-09-30 | $1.85B | $0.82B | 44.20% |
| 2011-06-30 | $1.81B | $0.80B | 44.32% |
| 2011-03-31 | $1.76B | $0.78B | 44.62% |
| 2010-12-31 | $1.70B | $0.76B | 44.54% |
| 2010-09-30 | $1.54B | $0.71B | 45.99% |
| 2010-06-30 | $1.49B | $0.69B | 46.15% |
| 2010-03-31 | $1.51B | $0.69B | 45.59% |
| 2009-12-31 | $1.55B | $0.70B | 45.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.756B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| CVS Health (CVS) | United States | $84.718B | 10.53 |
| Cencora (COR) | United States | $54.879B | 19.08 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |